Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetics of hypertension with spironolactone or torasemide
2020-001014-37Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in essential hypertension comparing Spironolactone arm with Torasemide arm (2 arms). Primary endpoint: Change in systolic blood pressure from baseline to 4 weeks. Started Oct 2020; status: completed.
02
Drugs
spironolactonetorasemide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2020-001014-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001014-37.